Wednesday, December 09, 2020 10:26:07 PM
This stock will be in its 5 year range soon with breakout momentum!
Moving steadily toward the long held range on significant company milestones.
If you want shares below the longstanding 5 year range,
Ya might think about getting them soon.
(stock continues to approach 5 year range on increasing volume)
Major business milestones are being met. More are pending near term.
The USA Hospitals are lined up next!! One more hospital signed up.
The U.S. based Trial Management Organization plans to launch 4 to 5 clinical study sites in 4Q2020
_________________________________
Expect patient updates! Two more patients treated for a total of 14 in phase 2 and 2 in phase 1
As a Fast Track designee, Theralase® will have access to early and frequent communications with the FDA to discuss Theralase's development plans and ensure timely collection of the appropriate clinical data to support the approval process. The accelerated communication with the FDA potentially allows, TLD-1433, in combination with the TLC-3200 medical laser system ("TLC-3200"), to be the first intravesical patient-specific Ruthenium-based PDC for the treatment of patients with BCG-Unresponsive NMIBC CIS, with or without papillary Ta or T1 tumours. FTD can lead to an Accelerated Approval and Priority Review, if certain criteria are met, which the FDA has previously defined to the Company to represent approximately 20 to 25 patients enrolled and treated, who demonstrate significant safety and efficacy clinical outcomes.
https://theralase.com/theralase-granted-fda-fast-track-designation-for-nmibc-phase-ii-clinical-study/
November 23, 2020
______________________
Virus updates pending as well.
Lung updates are pending.
Brain cancer updates are pending.
JMO, maybe, maybe not.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM